Description

1-Cyclopentyl-3-Ethyl-1,4,5,6-Tetrahydro-7H-Pyrazolo[3,4-C]Pyridin-7-One is a high-purity, advanced pharmaceutical intermediate belonging to the fused pyrazolopyridine class of heterocyclic compounds. This compound is of significant commercial interest for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring complex molecular architectures. It is primarily sought after by research institutions, custom synthesis organizations, and pharmaceutical companies engaged in the development of new chemical entities for drug discovery and process chemistry.

Application

• Pharmaceutical Intermediate: Serves as a key synthetic precursor in the research and development of new drug candidates, particularly for central nervous system (CNS) and oncology targets.
• Medicinal Chemistry Research: Used as a scaffold or building block for constructing compound libraries in high-throughput screening and structure-activity relationship (SAR) studies.
• Custom Synthesis & Contract Manufacturing: Employed by CDMOs (Contract Development and Manufacturing Organizations) for the scale-up and production of proprietary compounds under cGMP conditions.
• Biochemical Tool Compound: May be utilized in academic and industrial research as a probe to study specific biological pathways or enzyme inhibition.
• Process Chemistry Development: Acts as a critical intermediate in optimizing synthetic routes for cost-effective and scalable API manufacturing.

Basic Information

Product Name	1-Cyclopentyl-3-Ethyl-1,4,5,6-Tetrahydro-7H-Pyrazolo[3,4-C]Pyridin-7-One
CAS No.	162142-14-5
Molecular Formula	C13H19N3O
Molecular Weight	233.31 g/mol
Synonyms	7H-Pyrazolo[3,4-c]pyridin-7-one, 1,4,5,6-tetrahydro-1-cyclopentyl-3-ethyl-; 1-Cyclopentyl-3-ethyl-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-7-one; 1-Cyclopentyl-3-ethyl-1,4,5,6-tetrahydro-7H-pyrazolo[3,4-c]pyridin-7-one; 162142-14-5; UNII-8V7Q0S7T3I; 8V7Q0S7T3I; SCHEMBL218024; 1-cyclopentyl-3-ethyl-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-7-one
EINECS	Contact for details

Quality Control

Our production of 1-Cyclopentyl-3-Ethyl-1,4,5,6-Tetrahydro-7H-Pyrazolo[3,4-C]Pyridin-7-One adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity suitable for research and pharmaceutical applications. All materials are accompanied by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. We support development under quality systems aligned with ICH guidelines and can provide material manufactured under current Good Manufacturing Practice (cGMP) standards for advanced clinical stage requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to minimize exposure to moisture. For long-term storage, consider inert gas purging.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single unknown impurity ≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Loss on Drying	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.